Results 181 to 190 of about 2,585,234 (304)

Burden of disease among psoriatic patients

, 2020
Anna Éva Piros, Eszter Kun, Krisztina Herszényi, Hajnalka Jókai, Péter Holló   +4 more
openalex   +1 more source

Revisiting Mission‐Oriented Cancer Research to tackle the increasing burden of cancer in Europe–a policy perspective

Molecular Oncology, EarlyView.
Translational cancer research and its implementation through competitively selected Comprehensive Cancer Centers across Europe should be the primary policy focus for addressing the increasing cancer burden in Europe and counteract the present main strategy to convert cancer to a chronic disease.
Manuel Heitor, Julio Celis, Ulrik Ringborg   +2 more
wiley   +1 more source

Global Burden of Chronic Kidney Disease Among Hypertensive Patient Systematic- Review and Meta-Analysis

, 2021
Tiwabwork Tekalign, Nefsu Awoke, Hailu Asmare, Lielt G Selasie G Kirstos, Mistre Teshome, Molalegn Mesele, Mengistu Meskele   +6 more
openalex   +1 more source

Proteasome inhibitor, ixazomib prevents topoisomerase‐I degradation and reverses irinotecan resistance in colorectal cancer

Molecular Oncology, EarlyView.
Ixazomib inhibits proteasome‐mediated degradation of topoisomerase I induced by irinotecan, thereby restoring drug sensitivity and promoting tumor cell death in colorectal cancer. Irinotecan, a topoisomerase I (topoI) inhibitor, is widely used for colorectal cancer, but resistance remains a major clinical challenge.
Yuho Ebata, Koji Ando, Hirofumi Hasuda, Koshi Mimori, Elizabeth C. Unan, Siddhartha Pulukuri, Aahana Tiku, Allison Berger, Eiji Oki, Ajit Bharti, Tomoharu Yoshizumi   +10 more
wiley   +1 more source

Global, regional, and national burden of disease associated with low-fiber dietary patterns for colorectal cancer from 1990 to 2021: A systematic analysis for the global burden of disease 2021. [PDF]

Medicine (Baltimore)
Yin M, Wang A, Li H, Yang C, Cai Y, Zeng Y.   +5 more
europepmc   +1 more source

Whose Burden? Synthesizing Evidence from Diverse Perspectives for a Comprehensive Description of Disease Burden. [PDF]

, 2015
Amy Colquhoun, Arianna Waye, Karen J. Goodman   +2 more
openalex   +1 more source

Molecular cancer prevention: Intercepting disease

Molecular Oncology, EarlyView.
Oncological practice must evolve, from treating established tumours to proactive cancer interception before clinical manifestation. This will require mechanistic insight into tumour initiation, validated biomarkers of early disease development and redesigned clinical trials, enabling cancer interception to become a core pillar of oncology with the ...
Charlotte Grieco, Tej Pandya, Charles Swanton   +2 more
wiley   +1 more source

Global, regional, and national burden of epilepsy, 1990-2021: a Global Burden of Disease study. [PDF]

J Glob Health
Zhao J, Chen Q, Dong J, Gao M, Ge S, Wang A.   +5 more
europepmc   +1 more source

The Global Burden of Inflammation-Related Diseases in the Digestive System Among Adolescents and Adults Aged 15 to 49 Years from 1990 to 2021, Along with Forecasts of Prevalence for the Next 15 Years, Based on the Global Burden of Disease Study 2021

Haoyu Zhai, Mengtian Li, Yiwen Bao, Xue Chen, Bingwei Yang, C. Wang, Ying Wu, Muyao Cui, Jiahe Wu, Weidong Li   +9 more
openalex   +1 more source

The effect of changes in society, economy and public health on the disease burden of neurological, mental and substance use disorders: a global longitudinal study [PDF]

, 2019
Yankun Sun, Yao Yao, Yanping Bao, Yan Sun, Le Shi, Jie Shi, Lin Lü   +6 more
openalex   +1 more source